Zoetis (Germany) Performance
| ZOE Stock | EUR 166.98 1.72 1.02% |
The firm maintains a market beta of -0.14, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Zoetis are expected to decrease at a much lower rate. During the bear market, Zoetis is likely to outperform the market. At this point, Zoetis Inc has a negative expected return of -0.0323%. Please make sure to check out Zoetis' potential upside, daily balance of power, and the relationship between the maximum drawdown and kurtosis , to decide if Zoetis Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Zoetis Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Zoetis is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 3.5 B |
Zoetis |
Zoetis Relative Risk vs. Return Landscape
If you would invest 17,136 in Zoetis Inc on September 12, 2024 and sell it today you would lose (438.00) from holding Zoetis Inc or give up 2.56% of portfolio value over 90 days. Zoetis Inc is currently producing negative expected returns and takes up 1.2851% volatility of returns over 90 trading days. Put another way, 11% of traded stocks are less volatile than Zoetis, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Zoetis Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zoetis' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Zoetis Inc, and traders can use it to determine the average amount a Zoetis' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0251
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ZOE |
Estimated Market Risk
| 1.29 actual daily | 11 89% of assets are more volatile |
Expected Return
| -0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Zoetis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zoetis by adding Zoetis to a well-diversified portfolio.
Zoetis Fundamentals Growth
Zoetis Stock prices reflect investors' perceptions of the future prospects and financial health of Zoetis, and Zoetis fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zoetis Stock performance.
| Return On Equity | 0.47 | |||
| Return On Asset | 0.13 | |||
| Profit Margin | 0.26 % | |||
| Operating Margin | 0.36 % | |||
| Current Valuation | 71.14 B | |||
| Shares Outstanding | 463.39 M | |||
| Price To Earning | 36.15 X | |||
| Price To Book | 15.02 X | |||
| Price To Sales | 8.22 X | |||
| Revenue | 8.08 B | |||
| EBITDA | 3.34 B | |||
| Cash And Equivalents | 1.8 B | |||
| Cash Per Share | 3.76 X | |||
| Total Debt | 6.55 B | |||
| Debt To Equity | 285.30 % | |||
| Book Value Per Share | 9.50 X | |||
| Cash Flow From Operations | 1.91 B | |||
| Earnings Per Share | 4.24 X | |||
| Total Asset | 14.93 B | |||
About Zoetis Performance
By analyzing Zoetis' fundamental ratios, stakeholders can gain valuable insights into Zoetis' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Zoetis has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Zoetis has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. ZOETIS INC operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10000 people.Things to note about Zoetis Inc performance evaluation
Checking the ongoing alerts about Zoetis for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zoetis Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Zoetis Inc generated a negative expected return over the last 90 days | |
| Zoetis Inc has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Over 94.0% of the company outstanding shares are owned by institutional investors |
- Analyzing Zoetis' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zoetis' stock is overvalued or undervalued compared to its peers.
- Examining Zoetis' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Zoetis' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zoetis' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Zoetis' stock. These opinions can provide insight into Zoetis' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Zoetis Stock analysis
When running Zoetis' price analysis, check to measure Zoetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zoetis is operating at the current time. Most of Zoetis' value examination focuses on studying past and present price action to predict the probability of Zoetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zoetis' price. Additionally, you may evaluate how the addition of Zoetis to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |